Sanofi SA (EPA: SAN)‘s stock had its “outperform” rating reaffirmed by research analysts at Sanford C. Bernstein in a report released on Thursday. They currently have a $100.00 (€77) target price on the stock.

Shares of Sanofi SA traded up 0.90% during mid-day trading on Thursday, hitting €69.47. Sanofi SA has a 52 week low of €18.32 and a 52 week high of €25.15. The company has a market cap of €91.544 billion and a P/E ratio of 15.24.

A number of other analysts have also recently weighed in on SAN. Analysts at Exane BNP Paribas reiterated an “outperform” rating on shares of Sanofi SA in a research note to investors on Thursday, November 22nd. They now have a $97.44 price target on the stock. Separately, analysts at Societe Generale reiterated a “buy” rating on shares of Sanofi SA in a research note to investors on Monday, November 19th. They now have a $108.97 price target on the stock. Finally, analysts at AlphaValue reiterated an “add” rating on shares of Sanofi SA in a research note to investors on Thursday, November 8th. They now have a $97.56 price target on the stock.

Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.